|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-705.60/--
|
企业价值
2.14M
|
资产负债 |
每股账面净值
-0.10
|
现金流量 |
现金流量率
--
|
损益表 |
收益
75.40K
|
每股收益
0.01
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/10 16:06 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generatedfrom contracts with customers in the United States. |